Spectral Medical Inc. (TSX:EDT)
1.380
0.00 (0.00%)
Apr 28, 2026, 3:58 PM EST
Spectral Medical Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 2.44 | 2.29 | 1.6 | 1.67 | 2 | Upgrade
|
| Revenue Growth (YoY) | 6.82% | 43.05% | -4.14% | -16.48% | -5.00% | Upgrade
|
| Cost of Revenue | 1.12 | 1.57 | 0.94 | 0.68 | 0.79 | Upgrade
|
| Gross Profit | 1.33 | 0.71 | 0.66 | 0.98 | 1.21 | Upgrade
|
| Selling, General & Admin | 9.94 | 10.19 | 9.8 | 7.44 | 5.76 | Upgrade
|
| Other Operating Expenses | 0.27 | 0.74 | 0.32 | - | - | Upgrade
|
| Operating Expenses | 12.5 | 12.79 | 11.82 | 8.86 | 7.26 | Upgrade
|
| Operating Income | -11.18 | -12.08 | -11.16 | -7.88 | -6.05 | Upgrade
|
| Interest Expense | -5.16 | -3.18 | -1.33 | -0.18 | -0.03 | Upgrade
|
| Earnings From Equity Investments | - | - | -0.4 | 1 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 2.06 | -1.93 | 0.13 | -0.04 | -0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | -33.41 | 1.79 | -2.15 | -0.36 | -0.7 | Upgrade
|
| EBT Excluding Unusual Items | -47.69 | -15.4 | -14.91 | -7.46 | -6.83 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -0.6 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -0.17 | 0.03 | Upgrade
|
| Asset Writedown | - | - | - | - | -0.16 | Upgrade
|
| Pretax Income | -47.69 | -15.4 | -15.51 | -7.63 | -6.96 | Upgrade
|
| Earnings From Continuing Operations | -47.69 | -15.4 | -15.51 | -7.63 | -6.96 | Upgrade
|
| Earnings From Discontinued Operations | -0 | -0.01 | -0.16 | -3.65 | -1.83 | Upgrade
|
| Net Income | -47.69 | -15.4 | -15.66 | -11.28 | -8.79 | Upgrade
|
| Net Income to Common | -47.69 | -15.4 | -15.66 | -11.28 | -8.79 | Upgrade
|
| Shares Outstanding (Basic) | 287 | 281 | 279 | 270 | 252 | Upgrade
|
| Shares Outstanding (Diluted) | 287 | 281 | 279 | 270 | 252 | Upgrade
|
| Shares Change (YoY) | 2.18% | 0.90% | 3.23% | 6.88% | 8.59% | Upgrade
|
| EPS (Basic) | -0.17 | -0.05 | -0.06 | -0.04 | -0.03 | Upgrade
|
| EPS (Diluted) | -0.17 | -0.05 | -0.06 | -0.04 | -0.03 | Upgrade
|
| Free Cash Flow | -9.72 | -8.85 | -10.91 | -9.93 | -9.18 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.03 | -0.04 | -0.04 | -0.04 | Upgrade
|
| Gross Margin | 54.30% | 31.19% | 41.43% | 58.97% | 60.47% | Upgrade
|
| Operating Margin | -457.62% | -528.21% | -698.06% | -472.71% | -303.26% | Upgrade
|
| Profit Margin | -1952.99% | -673.75% | -980.10% | -676.73% | -440.13% | Upgrade
|
| Free Cash Flow Margin | -397.99% | -386.92% | -682.48% | -595.86% | -460.12% | Upgrade
|
| EBITDA | -11.05 | -11.95 | -11.04 | -7.7 | -5.85 | Upgrade
|
| EBITDA Margin | - | - | - | - | -293.19% | Upgrade
|
| D&A For EBITDA | 0.13 | 0.13 | 0.11 | 0.18 | 0.2 | Upgrade
|
| EBIT | -11.18 | -12.08 | -11.16 | -7.88 | -6.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.